221 related articles for article (PubMed ID: 27565433)
1. Lipoic acid and haloperidol-induced vacuous chewing movements: Implications for prophylactic antioxidant use in tardive dyskinesia.
Lister J; Andreazza AC; Navaid B; Wilson VS; Teo C; Nesarajah Y; Wilson AA; Nobrega JN; Fletcher PJ; Remington G
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jan; 72():23-29. PubMed ID: 27565433
[TBL] [Abstract][Full Text] [Related]
2. Behavioral and neurochemical effects of alpha lipoic acid associated with omega-3 in tardive dyskinesia induced by chronic haloperidol in rats.
de Araújo DP; Camboim TGM; Silva APM; Silva CDF; de Sousa RC; Barbosa MDA; Oliveira LC; Cavalcanti JRLP; Lucena EES; Guzen FP
Can J Physiol Pharmacol; 2017 Jul; 95(7):837-843. PubMed ID: 28329449
[TBL] [Abstract][Full Text] [Related]
3. Striatal cholinergic interneurons and D2 receptor-expressing GABAergic medium spiny neurons regulate tardive dyskinesia.
Bordia T; Zhang D; Perez XA; Quik M
Exp Neurol; 2016 Dec; 286():32-39. PubMed ID: 27658674
[TBL] [Abstract][Full Text] [Related]
4. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia.
Rogoza RM; Fairfax DF; Henry P; N-Marandi S; Khan RF; Gupta SK; Mishra RK
Synapse; 2004 Dec; 54(3):156-63. PubMed ID: 15452862
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol.
Egan MF; Hurd Y; Ferguson J; Bachus SE; Hamid EH; Hyde TM
Psychopharmacology (Berl); 1996 Oct; 127(4):337-45. PubMed ID: 8923569
[TBL] [Abstract][Full Text] [Related]
6. Haloperidol-Induced Preclinical Tardive Dyskinesia Model in Rats.
Guzen FP; Cavalcanti JRLP; Cavalcanti DMLP; de Sales LGP; da Silva MSM; da Silva ANA; Pinheiro FI; de Araújo DP
Curr Protoc Neurosci; 2019 Jun; 88(1):e68. PubMed ID: 31216395
[TBL] [Abstract][Full Text] [Related]
7. Effect of alpha lipoic acid on the tardive dyskinesia and oxidative stress induced by haloperidol in rats.
Thaakur S; Himabindhu G
J Neural Transm (Vienna); 2009 Jul; 116(7):807-14. PubMed ID: 19444377
[TBL] [Abstract][Full Text] [Related]
8. Extract of Ginkgo biloba is equivalent to vitamin E in attenuating and preventing vacuous chewing movements in a rat model of tardive dyskinesia.
An HM; Tan YL; Shi J; Wang ZR; Li J; Wang YC; Kosten TR; Zhou DF; Yang FD; Zhang XY
Behav Pharmacol; 2013 Oct; 24(7):610-6. PubMed ID: 23994817
[TBL] [Abstract][Full Text] [Related]
9. Ginkgo biloba and vitamin E ameliorate haloperidol-induced vacuous chewingmovement and brain-derived neurotrophic factor expression in a rat tardive dyskinesia model.
Shi J; Tan YL; Wang ZR; An HM; Li J; Wang YC; Lv MH; Yan SX; Wu JQ; Soares JC; Yang FD; Zhang XY
Pharmacol Biochem Behav; 2016 Sep; 148():53-8. PubMed ID: 27264436
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress and the antipsychotic-induced vacuous chewing movement model of tardive dyskinesia: evidence for antioxidant-based prevention strategies.
Lister J; Nobrega JN; Fletcher PJ; Remington G
Psychopharmacology (Berl); 2014 Jun; 231(11):2237-49. PubMed ID: 24752659
[TBL] [Abstract][Full Text] [Related]
11. Excitatory mechanisms in neuroleptic-induced vacuous chewing movements (VCMs): possible involvement of calcium and nitric oxide.
Naidu PS; Kulkarni SK
Behav Pharmacol; 2001 Jun; 12(3):209-16. PubMed ID: 11485057
[TBL] [Abstract][Full Text] [Related]
12. Naringin Ameliorates Haloperidol-Induced Neurotoxicity and Orofacial Dyskinesia in a Rat Model of Human Tardive Dyskinesia.
Wang MH; Yang CC; Tseng HC; Fang CH; Lin YW; Soung HS
Neurotox Res; 2021 Jun; 39(3):774-786. PubMed ID: 33523404
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of EGb761 and vitamin E on haloperidol-induced vacuous chewing movements in rats: Possible involvement of S100B mechanisms.
An HM; Tan YL; Shi J; Wang ZR; Li J; Wang YC; Lv MH; Zhou DF; Soares JC; Kosten TR; Yang FD; Zhang XY
Behav Brain Res; 2016 Jan; 297():124-30. PubMed ID: 26455874
[TBL] [Abstract][Full Text] [Related]
14. Mixture in the distribution of haloperidol-induced oral dyskinesias in the rat supports an animal model of tardive dyskinesia.
Hashimoto T; Ross DE; Gao XM; Medoff DR; Tamminga CA
Psychopharmacology (Berl); 1998 May; 137(2):107-12. PubMed ID: 9629996
[TBL] [Abstract][Full Text] [Related]
15. Protective Effect of L-Theanine on Haloperidol-Induced Orofacial.
Chen CN; Chang KC; Wang MH; Tseng HC; Soung HS
Chin J Physiol; 2018 Feb; 61(1):35-41. PubMed ID: 29374957
[TBL] [Abstract][Full Text] [Related]
16. Harpagophytum Procumbens Ethyl Acetate Fraction Reduces Fluphenazine-Induced Vacuous Chewing Movements and Oxidative Stress in Rat Brain.
Schaffer LF; de Freitas CM; Chiapinotto Ceretta AP; Peroza LR; de Moraes Reis E; Krum BN; Busanello A; Boligon AA; Sudati JH; Fachinetto R; Wagner C
Neurochem Res; 2016 May; 41(5):1170-84. PubMed ID: 26732278
[TBL] [Abstract][Full Text] [Related]
17. Autoradiographic mapping of mu opioid receptor changes in rat brain after long-term haloperidol treatment: relationship to the development of vacuous chewing movements.
Sasaki T; Kennedy JL; Nobrega JN
Psychopharmacology (Berl); 1996 Nov; 128(1):97-104. PubMed ID: 8944412
[TBL] [Abstract][Full Text] [Related]
18. Parallels between behavioral and neurochemical variability in the rat vacuous chewing movement model of tardive dyskinesia.
Bachus SE; Yang E; McCloskey SS; Minton JN
Behav Brain Res; 2012 Jun; 231(2):323-36. PubMed ID: 22503783
[TBL] [Abstract][Full Text] [Related]
19. The relationship between dopamine D2 receptor occupancy and the vacuous chewing movement syndrome in rats.
Turrone P; Remington G; Kapur S; Nobrega JN
Psychopharmacology (Berl); 2003 Jan; 165(2):166-71. PubMed ID: 12417967
[TBL] [Abstract][Full Text] [Related]
20. A novel brain-targeted antioxidant (AD4) attenuates haloperidol-induced abnormal movement in rats: implications for tardive dyskinesia.
Sadan O; Bahat-Stromza M; Gilgun-Sherki Y; Atlas D; Melamed E; Offen D
Clin Neuropharmacol; 2005; 28(6):285-8. PubMed ID: 16340385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
